GLP-1 medications have fundamentally changed how providers and patients think about weight management. Semaglutide — the active ingredient in Ozempic and Wegovy — has become one of the most talked-about drug classes in years, and for good reason: clinical studies have consistently associated GLP-1 receptor agonists with meaningful reductions in body weight and improvements in metabolic markers, when prescribed as part of a comprehensive care plan.
But access hasn't kept pace with demand. Commercial semaglutide products have faced ongoing supply constraints, cost barriers, and insurance hurdles that leave many patients without a path forward. That gap is exactly where compounded semaglutide — prepared by a licensed 503A compounding pharmacy — enters the conversation.
As a licensed 503A compounding pharmacy serving Eastern Iowa across seven locations, Towncrest Pharmacy believes patients deserve a clear, honest explanation of what compounded semaglutide actually is, how it's regulated, and what a responsible path to access looks like. This is that explanation — written by pharmacists, not a telehealth app or a weight-loss brand.
What Is Compounded Semaglutide?
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist — a class of medications that work by mimicking a hormone your body naturally produces after eating. GLP-1 receptor agonists help regulate blood sugar, slow gastric emptying, and signal fullness to the brain. Several GLP-1 medications are FDA-approved for type 2 diabetes management and, in higher doses, for chronic weight management in qualifying patients.
Compounded semaglutide refers to a patient-specific preparation of semaglutide made by a licensed 503A compounding pharmacy — like Towncrest — based on an individual prescription from a licensed prescriber. Unlike commercially manufactured products that are mass-produced in fixed doses and formulations, compounded semaglutide is prepared for one patient at a time, to meet that patient's specific clinical needs.
Patients seek compounded formulations for a variety of reasons:
- Access: Commercial semaglutide products have experienced significant and documented supply shortages. During shortage periods, 503A compounders may legally prepare patient-specific compounds to help fill the gap.
- Cost: Commercial GLP-1 medications can exceed $1,000 per month without insurance coverage. Compounded alternatives may offer a more accessible price point for patients who need them.
- Formulation flexibility: Compounders can prepare semaglutide in formulations tailored to individual patient needs — including allergen-free preparations or alternative dosing forms as clinically appropriate and as prescribed.
- Titration customization: A prescriber may want a patient on a specific titration schedule that differs from the fixed dosing increments of commercially available products.
It's important to be clear about what compounded semaglutide is not: it is not FDA-approved, it is not commercially manufactured, and it is not available over the counter or without a valid prescription. Every compounded preparation at Towncrest is made based on an individual patient prescription, in compliance with 503A regulations and Iowa Board of Pharmacy standards.
Compounded Semaglutide vs. Commercially Available Semaglutide: What's the Difference?
This is one of the most common questions patients bring to a consultation — and it deserves a straightforward answer.
The active ingredient — semaglutide — is the same molecule. What differs is the manufacturing pathway, the regulatory framework, and what goes into the finished preparation.
Regulatory status: Commercially manufactured semaglutide products (Ozempic, Wegovy, Rybelsus) are FDA-approved drugs that have undergone clinical trials for safety and efficacy in specific indications. Compounded semaglutide prepared by a 503A pharmacy is not FDA-approved. It is, however, legally prepared under federal pharmacy compounding law when specific conditions are met — including a valid patient-specific prescription and, in recent years, a documented drug shortage.
Formulation differences: Commercial products come in fixed concentrations, delivery mechanisms, and inactive ingredient profiles. A 503A compounder can prepare semaglutide with different diluents or, as directed by a prescriber, with complementary ingredients. One formulation that's generated considerable patient interest is semaglutide combined with cyanocobalamin — a form of B12.
Semaglutide with cyanocobalamin vs. Ozempic: Some prescribers choose to combine semaglutide with cyanocobalamin (vitamin B12) in a compounded preparation. The rationale is that GLP-1 medications can affect appetite and dietary intake in ways that may impact B12 status over time, and some patients may benefit from B12 support as part of their protocol. Ozempic does not contain B12. This is not a claim that the combination is superior — it is a formulation option that a prescriber may choose based on individual patient needs. As with all compounded preparations at Towncrest, this is prepared only as prescribed by your healthcare provider.
What "pharmaceutical-grade" means in 503A compounding: At Towncrest, compounded semaglutide is prepared using pharmaceutical-grade active pharmaceutical ingredients (APIs) sourced from suppliers that meet USP standards. Our pharmacists follow strict compounding protocols, and our lab operates under Iowa Board of Pharmacy oversight. This is meaningfully different from unregulated online sellers offering "semaglutide" without a prescription — a distinction we address directly in the next section.
What 503A compounding does not include: bulk manufacturing for general sale, dispensing without a prescription, or sale to patients without a valid prescriber-patient relationship. One patient, one prescription, one preparation.
What About the FDA and Compounded Semaglutide? Here's What's Actually Happening
If you've searched for compounded semaglutide, you've likely encountered FDA warning pages and news coverage about unapproved GLP-1 drugs. It's worth addressing this directly, because the situation is nuanced — and getting it right matters for patient safety.
The FDA's position: The FDA has raised legitimate concerns about compounded semaglutide, particularly as it relates to unregulated online sellers and non-pharmacy entities offering injectable drugs without prescriptions or proper oversight. The FDA has also issued guidance related to shortage designations — specifically, that compounding of certain drugs is only permitted under shortage conditions, and that as commercial supply stabilizes, those permissions may be revisited.
The critical distinction: There is a significant difference between a licensed 503A compounding pharmacy — operating under state board oversight, dispensing only on valid prescriptions, sourcing pharmaceutical-grade APIs — and an unregulated online storefront selling injectable compounds with no clinical oversight. The FDA's enforcement actions have largely targeted the latter.
What to look for in a compounding pharmacy:
- Licensed by the state board of pharmacy in the state where it operates
- LegitScript certified — a rigorous third-party pharmacy verification standard
- Dispensing only on valid individual patient prescriptions
- Transparent about API sourcing and compounding standards
- Not advertising semaglutide for direct purchase online without a prescription
Towncrest Pharmacy holds LegitScript certification and operates under Iowa Board of Pharmacy licensing. Every compounded preparation we make is based on an individual patient prescription. We do not sell compounded medications without a valid prescriber-patient relationship.
What patients should do: If you are currently receiving compounded semaglutide from an online source you cannot verify, or without having had a clinical consultation, we strongly encourage you to discuss this with a licensed provider. The clinical risks of unverified injectable compounds are real. The path to safe access runs through a licensed pharmacy and a qualified prescriber.
Is Compounded Semaglutide Safe?
The honest answer: safety depends almost entirely on the source.
Compounded semaglutide prepared by a licensed, accredited 503A pharmacy — using pharmaceutical-grade APIs, following USP compounding standards, dispensed on a valid prescription with clinical oversight — represents a meaningfully different risk profile than an injectable purchased from an unverified online seller.
At Towncrest, our compounding lab operates under the oversight of licensed pharmacists, follows strict quality and sourcing protocols, and prepares every compound based on a valid prescription. Patients don't receive a vial; they receive a clinical relationship.
That said, semaglutide — whether commercially manufactured or compounded — is not appropriate for every patient. Side effects commonly associated with the GLP-1 drug class include nausea, vomiting, diarrhea, and GI discomfort, particularly during the titration phase. These are characteristics of the drug class, not unique to compounded formulations. There are also patients for whom semaglutide is contraindicated based on personal or family medical history.
This is precisely why a consultation matters before starting. A clinical evaluation — including a review of your health history, current medications, and goals — is the responsible first step. It's also why Towncrest's model is built around the consultation, not the transaction.
How a Consultation at Towncrest Works
Towncrest's owner and pharmacist-prescriber, Aaron, is credentialed to prescribe in Iowa — a distinction that sets Towncrest apart from most compounding pharmacies, where patients must obtain a prescription from a separate provider before the compounding relationship can begin.
At Towncrest, the consultation, prescribing decision, and compounding can happen within a single practice. For patients in Eastern Iowa seeking a local, clinically grounded alternative to mail-order GLP-1 programs, this integrated model offers something meaningfully different.
What a consultation covers:
- A review of your health history, current medications, and relevant labs
- A conversation about your goals and whether GLP-1 therapy may be appropriate for your situation
- If appropriate, a prescribing decision and a compounded formulation tailored to your protocol
- A clear titration plan and follow-up structure — because starting a GLP-1 is the beginning of a clinical relationship, not the end of a transaction
Consultations are available in person at Towncrest's Iowa City, Solon, Marengo, New Hampton, and Wellness Apothecary locations, as well as via telehealth for patients located in Iowa.
Prescribing and compounding services are available only to patients located in Iowa.
Ready to explore whether compounded semaglutide may be appropriate for your situation? Schedule a consultation with our pharmacist-prescriber.
A Note for Prescribers: Referring Patients to Towncrest's Compounding Lab
If you are a prescriber in Iowa or surrounding states who works with patients on GLP-1 therapy, Towncrest's 503A compounding lab is available as a reliable, accredited compounding partner.
How to refer: A valid patient-specific prescription for compounded semaglutide, written to Towncrest Pharmacy, is all that's required to initiate compounding. Our pharmacists are available to discuss formulation options, dosing ranges, and titration schedules before you write the script.
What Towncrest's lab can provide:
- Compounded semaglutide preparations in clinically appropriate formulations as prescribed, including cyanocobalamin-containing combinations where indicated
- Customized dosing and titration-ready preparations built to your protocol
- Consistent turnaround times and pharmacist-to-prescriber communication throughout the patient's protocol
- A team that understands the clinical landscape for GLP-1 therapy and can speak your language
To establish a prescriber relationship or discuss a patient case, contact Towncrest's Iowa City compounding team at (319) 337-3526 or reach us at hello@towncrest.com.
Frequently Asked Questions
What is compounded semaglutide?
Compounded semaglutide is a patient-specific preparation of semaglutide — the active ingredient in GLP-1 medications like Ozempic and Wegovy — made by a licensed 503A compounding pharmacy based on an individual patient prescription. It is not FDA-approved and is not commercially manufactured. It is prepared to meet individual patient needs, as prescribed by a licensed healthcare provider.
Is compounded semaglutide the same as Ozempic?
No — and the distinction matters. The active ingredient, semaglutide, is the same molecule. However, compounded semaglutide is not FDA-approved, is prepared by a compounding pharmacy rather than a commercial manufacturer, and may differ in formulation, concentration, or inactive ingredients. It is not interchangeable with Ozempic or Wegovy and should not be treated as equivalent.
Is compounded semaglutide legal?
Yes, when prepared by a licensed 503A compounding pharmacy based on a valid individual patient prescription and under conditions permitted by federal and state compounding law. The legality depends entirely on the source. Compounded semaglutide sold online without a prescription, or by unlicensed operations, is not legal and carries significant patient safety risk. Towncrest is a LegitScript-certified, Iowa Board of Pharmacy–licensed 503A compounder.
How do I get compounded semaglutide in Iowa?
The responsible path begins with a clinical consultation. At Towncrest Pharmacy, our pharmacist-prescriber can evaluate whether GLP-1 therapy may be appropriate for your situation, prescribe if warranted, and compound your medication — all within a single practice. Consultations are available in person at our Iowa City, Solon, Marengo, New Hampton, and Wellness Apothecary locations, and via telehealth for Iowa-based patients. Schedule a consultation here.
Does Towncrest Pharmacy compound semaglutide?
Yes. Towncrest Pharmacy is a licensed Iowa 503A compounding pharmacy with a state-of-the-art compounding lab. We prepare compounded semaglutide based on individual patient prescriptions, in compliance with 503A regulations and Iowa Board of Pharmacy standards. To learn more or schedule a consultation, contact us here.
The Towncrest Difference: One Partner for Rx, Compounding, and Clinical Care
The GLP-1 conversation has gotten noisy — app-based prescribers, mail-order vials, online pharmacies of uncertain provenance. Iowa patients deserve better than that noise.
Towncrest Pharmacy offers something different: a licensed 503A compounding lab, a pharmacist-prescriber on staff, and a clinical model built around your individual needs — not a subscription box. Whether you're a patient exploring your options or a prescriber looking for a compounding partner you can trust, we're here.
Schedule a consultation with our pharmacist-prescriber to explore whether compounded semaglutide may be appropriate for your situation.
Find your nearest Towncrest location: Iowa City · Solon · Marengo · New Hampton · Wellness Apothecary
This content is for informational purposes only and does not constitute medical advice. Compounded medications are prepared based on individual patient prescriptions and are not FDA approved. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new medication or supplement. Prescribing services are available only to patients located in Iowa.